CAS Number2095200-69-2
SynonymsCyclic tedizolid phosphate; Cyclic tedizolid phosphate impurity reference; Tedizolid impurity 42; Tedizolid solid impurity Q; Tedizolid impurity 19: Cyclic tedizolid phosphate; Tedizolid impurity 34; Tedizolid impurity 570; Tedizolid phosphate impurity E
Molecular FormulaC16H18FN6O5P
Molecular Weight424.32
Density1.65±0.1 g/cm3(Predicted)
Boiling Point759.4±70.0 °C(Predicted)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 2095200-69-2 |
| Catalog No. | 2A-0202146 |
| Chinese Name | 特地唑胺杂质34 |
| Synonyms | Cyclic tedizolid phosphate; Cyclic tedizolid phosphate impurity reference; Tedizolid impurity 42; Tedizolid solid impurity Q; Tedizolid impurity 19: Cyclic tedizolid phosphate; Tedizolid impurity 34; Tedizolid impurity 570; Tedizolid phosphate impurity E |
| Molecular Formula | C16H18FN6O5P |
| Molecular Weight | 424.32 |
| Density | 1.65±0.1 g/cm3(Predicted) |
| Boiling Point | 759.4±70.0 °C(Predicted) |
| PubChem ID | 463585976 |
| InChI | InChI=1S/C16H18FN6O5P/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)17)18-8-12(24)9-28-29(25,26)27/h2-7,12,18,24H,8-9H2,1H3,(H2,25,26,27)/t12-/m1/s1 |
| InChI Key | SLWZUYSGVBYIAO-GFCCVEGCSA-N |
| Related Products in Analytical Standards | ||
|---|---|---|
| Atorvastatin 10-Trans (Atorvastatin Impurity AT10) | 131275-93-9 | 2A-3184998 |
| Palbociclib impurity 33 | 1974279-40-7 | 2A-3185009 |
| Palbociclib Impurity 87 | 571189-51-0 | 2A-3185010 |
| Palbociclib Impurity I | 2172256-78-7 | 2A-3185013 |
| Tedizolid Impurity 3 | 1835340-19-6 | 2A-3185018 |
| vildagliptin Impurity E | 1789703-37-2 | 2A-3185039 |
| Levosimendan impurity 6/Acetamide,N-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-, (R)- | 39052-02-1 | 2A-3185042 |
| Irinotecan Impurity 26 | 86639-51-2 | 2A-3185489 |
| Cefalexin IMpurity ( 3-aMinoMethylene-6-phenylpiperazine-2,5-dione) | 65870-51-1 | 2A-3185554 |
| Vortioxetine iMpurity | 853745-55-8 | 2A-3185555 |
| Browse all Analytical Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS